BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 27599725)

  • 21. Prognostic Importance of Atrial Fibrillation Timing and Pattern in Adults With Congestive Heart Failure: A Systematic Review and Meta-Analysis.
    Odutayo A; Wong CX; Williams R; Hunn B; Emdin CA
    J Card Fail; 2017 Jan; 23(1):56-62. PubMed ID: 27565044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database).
    Baldasseroni S; De Biase L; Fresco C; Marchionni N; Marini M; Masotti G; Orsini G; Porcu M; Pozzar F; Scherillo M; Maggioni AP;
    Eur Heart J; 2002 Nov; 23(21):1692-8. PubMed ID: 12398827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Nielsen JC; Sørensen HT
    Int J Cardiol; 2016 Dec; 225():30-36. PubMed ID: 27705839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
    Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resting heart rate trajectories and myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: The Tromsø Study.
    Sharashova E; Wilsgaard T; Løchen ML; Mathiesen EB; Njølstad I; Brenn T
    Eur J Prev Cardiol; 2017 May; 24(7):748-759. PubMed ID: 28121181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
    Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
    Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study.
    Mitsuma W; Matsubara T; Hatada K; Imai S; Saito N; Shimada H; Miyazaki S
    J Cardiol; 2016 Aug; 68(2):148-55. PubMed ID: 26527113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Nordio F; Corbalán R; Dalby A; Dorobantu M; Mercuri M; Lanz H; Rutman H; Wiviott SD; Antman EM; Giugliano RP
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Lin YS; Tung TH; Wang J; Chen YF; Chen TH; Lin MS; Chi CC; Chen MC
    Int J Cardiol; 2016 Jan; 203():204-11. PubMed ID: 26512838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
    Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cause-specific mortality after stroke: relation to age, sex, stroke severity, and risk factors in a 10-year follow-up study.
    Mogensen UB; Olsen TS; Andersen KK; Gerds TA
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e59-65. PubMed ID: 22578918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies.
    Aune D; Sen A; ó'Hartaigh B; Janszky I; Romundstad PR; Tonstad S; Vatten LJ
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):504-517. PubMed ID: 28552551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
    Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Vasiljevic ZM; Vujisic-Tesic BD; Marinkovic JM; Polovina MM; Stepanovic JM; Stankovic GR; Ostojic MC; Lip GYH
    Chest; 2011 Oct; 140(4):902-910. PubMed ID: 21436252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
    Bassand JP; Accetta G; Al Mahmeed W; Corbalan R; Eikelboom J; Fitzmaurice DA; Fox KAA; Gao H; Goldhaber SZ; Goto S; Haas S; Kayani G; Pieper K; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK;
    PLoS One; 2018; 13(1):e0191592. PubMed ID: 29370229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.